593 Drug Safety and the FDA

The FDA has come under heavy criticism for its handling of Vioxx, the popular arthritis drug that was taken off the market in 2004 because it increased the risk of strokes and heart attacks. Can the agency protect Americans from another Vioxx-type scandal?
Guests: David Graham, MD, associate director of medicine and safety in the FDA’s Office of Drug Safety.
Peter Rost, MD, a former Vice President of Pfizer. His blog is at: http://peterrost.blogspot.com/
Susan Okie, MD, Contributing Editor for the New England Journal of Medicine. She was formerly a medical reporter and science editor for the Washington Post.